Vanguard Global Advisers »

Lb Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $216k 8.8k 24.66

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
TCG Crossover Management
Commodore Capital
Trails Edge Capital Partners
Vanguard Group
Nantahala Capital Management
Balyasny Asset Management
Logos Global Management
Vanguard Capital Management
Alyeska Investment Group
Vivo Capital
Jennison Associates
Geode Capital Management

View all funds holding Lb Pharmaceuticals